Showing BioInteractions for Risedronic acid (DB00884)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Risedronic acid is a Farnesyl pyrophosphate synthase inhibitor | ||
| 1 | Farnesyl pyrophosphate synthase inhibitors | Alendronic acid, Ibandronate, Incadronic acid, Minodronic acid, Pamidronic acid, Zoledronic acid |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Risedronic acid is a Hydroxylapatite antagonist | ||
| 1 | Hydroxylapatite antagonists | Alendronic acid, Clodronic acid, Etidronic acid, Ibandronate, Pamidronic acid, Tiludronic acid, Zoledronic acid |
| 2 | Hydroxylapatite binders | Tiludronic acid, Zoledronic acid |
| 3 | Hydroxylapatite modulators | Gallium nitrate |